Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar plus concurrent chemoradiotherapy for locally advanced cervical cancer
ChiCTR1800018585Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of endostar in Cervical Cancer (CC), sponsored by First Affiliated Hospital of Soochow University. Primary endpoints: Objective response rate and Disease control rate. Started Nov 2018; status: recruiting.
02
Drugs
endostar
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR1800018585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018585.